PlainRecalls
FDA Devices Moderate Class II Terminated

QIAstat-Dx Respiratory SARS-CoV-2 Panel (US IVD under FDA EUA 200075); REF 691223

Reported: January 12, 2022 Initiated: November 8, 2021 #Z-0455-2022

Product Description

QIAstat-Dx Respiratory SARS-CoV-2 Panel (US IVD under FDA EUA 200075); REF 691223

Reason for Recall

The firm identified sixteen (16) faulty cartridges in LOT 210209, which contain incorrect primer-probe mixes in the reaction chambers. If an affected cartridge is used, false-negative, false-positive, or both false-negative and false-positive results could occur.

Details

Recalling Firm
Qiagen Sciences LLC
Units Affected
376 kits
Distribution
Domestic distribution to AL, DC, KY, MD, ME, NJ, OK< PA, and TX. No foreign distribution.
Location
Germantown, MD

Frequently Asked Questions

What product was recalled?
QIAstat-Dx Respiratory SARS-CoV-2 Panel (US IVD under FDA EUA 200075); REF 691223. Recalled by Qiagen Sciences LLC. Units affected: 376 kits.
Why was this product recalled?
The firm identified sixteen (16) faulty cartridges in LOT 210209, which contain incorrect primer-probe mixes in the reaction chambers. If an affected cartridge is used, false-negative, false-positive, or both false-negative and false-positive results could occur.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 12, 2022. Severity: Moderate. Recall number: Z-0455-2022.